Epizyme

ESMO: It’s early days for Pfizer’s EZH2 inhibitor, but there’s a glimpse of hope for some
Fierce Biotech
Sun, 09/11/22 - 10:58 pm
ESMO
Pfizer
Ipsen
EZH2 inhibitors
Epizyme
Epizyme SEC filing details its desperate days in free fall before $247M sale to Ipsen
Fierce Pharma
Wed, 07/13/22 - 10:09 am
Epizyme
SEC
M&A
Ipsen
Epizyme joins the queue of biotechs now handing out pink slips, conserving cash
Endpoints
Tue, 03/1/22 - 10:14 pm
Epizyme
layoffs
restructuring
R&D
Epizyme pairs real-life nurse with interactive tool to help follicular lymphoma patients navigate the tough questions
Fierce Pharma
Fri, 11/19/21 - 11:14 am
Epizyme
pharma marketing
follicular lymphoma
Big Pharma Is Going Holiday Shopping. Who's Next?
Motley Fool
Wed, 11/10/21 - 10:13 am
Big Pharma
M&A
ChemoCentryx
Epizyme
Magenta Therapeutics
CEO Steps Down as Epizyme Finalizes 5-Year Growth Strategy
BioSpace
Tue, 08/10/21 - 11:15 pm
Epizyme
Pharma CEOs
Robert Bazemore
EHA: Epizyme's first-in-class multiple myeloma drug candidate inhibits tumors in mice
Fierce Biotech
Mon, 06/14/21 - 10:41 am
EHA
Epizyme
Multiple Myeloma
EPZ-719
Fortunes diverge for solo drug launchers
EP Vantage
Tue, 05/11/21 - 11:01 am
drug launches
Intra-Cellular Therapies
Biocryst
Horizon Therapeutics
Karyopharm Therapeutics
Blueprint Medicines
Zogenix
Esperion
Epizyme
Aurinia Pharmaceuticals
Global Blood Therapeutics
Epizyme's Tazverik Wins FDA Approval to Treat Follicular Lymphoma
Motley Fool
Thu, 06/18/20 - 08:29 pm
Epizyme
FDA
Tazverik
follicular lymphoma
Epizyme eyes lucrative use for newly-launched Tazverik
Pharmaforum
Tue, 02/18/20 - 10:22 am
Epizyme
FDA
Tazverik
follicular lymphoma
Epizyme's Cancer Drug to Get Rapid FDA Review for a New Indication
Motley Fool
Fri, 02/14/20 - 04:58 pm
Epizyme
FDA
tazemetostat
follicular lymphoma
Epizyme drug granted approval by FDA for rare cancer
BioPharma Dive
Thu, 01/23/20 - 11:52 pm
Epizyme
FDA
Tazverik
Eisai
epithelioid sarcoma
Migraine, cholesterol upstarts top the list of FDA decisions to watch this quarter
Fierce Pharma
Fri, 01/3/20 - 11:03 pm
FDA
migraines
cholesterol
Epizyme
tazemetostat
Esperion
bempedoic acid
teprotumumab
Horizon Therapeutics
Biohaven
rimegepant
FDA’s in-house review offers bleak assessment of Epizyme’s tazemetostat — but win or lose this cancer drug may still have a future
Endpoints
Tue, 12/17/19 - 10:27 am
Epizyme
FDA
tazemetostat
epithelioid sarcoma
The Week Ahead In Biotech: Avadel, Epizyme In Focus In A Quiet Week
Yahoo/Benzinga
Sun, 12/15/19 - 11:28 pm
Epizyme
tazemetostat
Avadel
AV001
FDA
Where Will Epizyme Be in 1 Year?
Motley Fool
Thu, 09/5/19 - 10:03 am
Epizyme
Epizyme announces FDA filing acceptance of new drug application and priority review for tazemetostat to treat epithelioid sarcoma
Pharmaceutical Business Review
Fri, 07/26/19 - 11:02 am
Epizyme
FDA
tazemetostat
epithelioid sarcoma
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/16/19 - 05:41 pm
FDA
Merck
Arqule
Affimed
BeiGene
Epizyme
MorphoSys
Theravance
Allena Pharma
Akero Therapeutics
Atreca
Dermavant Sciences
Personalis
Prevail Therapeutics
Stoke Therapeutics
IPOs
ASCO: With FDA review nearing, Epizyme shares updated sarcoma data
Fierce Biotech
Mon, 06/3/19 - 11:32 am
ASCO 2019
Epizyme
clinical trials
tazemetostat
epithelioid sarcoma
Epizyme moves forward with cancer drug, eyes 2020 launch
Biopharma Dive
Thu, 05/30/19 - 05:37 pm
Epizyme
FDA
tazemetostat
epithelioid sarcoma

Pages